SlideShare a Scribd company logo
1 of 8
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 3
Channels
October 15, 2013
Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com
UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE MARKETS ARE
PHYSICAL MARKETS


Medical devices encompass a large range of tangible and intangible
items with a wide variety of business models and issues











Imaging equipment, such as MRI, CT and ultrasound
Therapeutic capital equipment, such as Stereotactic radiosurgery, lasers, and
surgical robots
Implants, such as total joints, pacemakers, stents, and artificial corneas
Instruments and tools, such as scalpels, syringes, and electrocautery
Devices, such as catheters, introducers, and sheaths
Monitoring equipment, such as glucometers, pulse oximetry, and vital signs
monitors
Durable medical equipment, such as crutches, wheelchairs, and home oxygen
Disposables, such as syringes, wound dressings, and casts

Medical devices generally require physical delivery


Exceptions:
 Software based products
 Morpheus: Enhanced imaging data via post processing
 Physician office management software
 Big Data based products

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE CHANNELS TEND TO BE DIRECT



Most devices are sold to hospitals, physicians or patients directly
Most medical devices require direct sales




There is often an educational/training component to the sales known as the
“learning curve”
Sales and clinical applications personnel often guide physicians through the
learning curve
In some products, sales and clinical applications specialists attend each procedure
at which the device is used




Commonly a sales rep and tech rep send an entire day to assist a single product usage

Some Medical device products/sectors use distributors




Distribution channels vary by clinical area: Eg, spine devices and surgical
instruments tend to use distributors
Commodity type items, such as hospital supplies, tend to use distributors
Distribution channels also vary by geography
 OUS markets tend to be much more distributor dominated

UCSF Lean Launchpad - Allan May ©
MEDICAL DEVICE CHANNELS TEND TO BE
DIRECT (2)
 OEMing components to larger manufactures is
generally low margin, hard to exit businesses


The negotiating power lies mainly with the manufacturer

 VARs are virtually non-existent since any alterations
of approved devices require separate clinical trials
and regulatory approvals


EG, adding a steroid to the tip of a pacemaker to prevent fibrosis

 Retail channels exist but solely in consumer products


Hearing aids, eye glasses, wound dressings

UCSF Lean Launchpad - Allan May ©
MARKETING AND SELLING MEDICAL DEVICES
CAN BE A RISKY STRATEGY



Getting and keeping medical device customers often results in
wasteful duplication of resources
GMP manufacturing, quality systems, QA/QC, and sales and
marketing infrastructure are required in order to Market and Sell


These systems and processes are very expensive to finance




Sales people tend to cost >$350-400k/year fully loaded




It normally takes one or more dilutive equity rounds

Clinical applications or technical support specialists are required to
assist sales and marketing

Most acquirers have extensive manufacturing infrastructure and
dedicated sales and marketing forces



So they don’t pay extra value in exits for duplicative resources
They DO pay for proof of penetration and uptake, but that tends to
take >1-2 years and be very expensive in terms of cash burn


Requires substantial funding capital usually from venture capitalists or
corporate venture capital groups

UCSF Lean Launchpad - Allan May ©
ALTERNATIVE STRATEGIES FOR SELLING
MEDICAL DEVICES
 What is it you are trying to prove?




Revenue, or revenue ramp to get a multiple of sales on exit?
KOL uptake?
Clinical viability?

 Building a sales and marketing force and ramping
sales is expensive, risky and time consuming
 A targeted, focused rollout can be equally effective
 Converting key customers of strategics is a very
effective way to get the attention of acquirers






Target hospitals where their KOLs practice
Target major hospitals/customers in their sales channel
Demonstrate physician/patient satisfaction and build clinical
experience

Price/Dreams beats Price/Earnings in most cases!

UCSF Lean Launchpad - Allan May ©
CHANNEL PROFIT FIT IN MEDICAL
DEVICES
 Gross margin impacts distribution method and exit
 First Gen medical devices often have 40-50% margins


Medical device distributors tend to require >25% margins, which is a major reason
distribution is often not a viable channel

 Normally, all available cash in medical device startups is
spent proving safety and efficacy


Cost engineering or cost reduction usually comes in the Series C round or later


It commonly takes 6-12 months (or longer) to reduce costs and maintain safety and
efficacy

 Medical device acquirers will require products with >65%
margins




Sometimes a clear engineering pathway to COGs reductions is sufficient without
actually spending the cash to prove it
Sometimes larger volumes driven by the large sales and marketing forces of major
device companies can achieve COGS and economies of scale unobtainable by
startups

UCSF Lean Launchpad - Allan May ©
UCSF Lean Launchpad For Life Science
and Healthcare Startups
Medical Device Track
Class 3
Channels
October 15, 2013
Allan May
Chairman, Life Science Angels
amay@lifescienceangels.com

UCSF Lean Launchpad - Allan May ©

More Related Content

What's hot

Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
 
Cola war continues: Coke and Pepsi 21st century and battle for Internationa...
Cola war  continues: Coke and Pepsi 21st century and battle for  Internationa...Cola war  continues: Coke and Pepsi 21st century and battle for  Internationa...
Cola war continues: Coke and Pepsi 21st century and battle for Internationa...Sulabh Subedi
 
Indian pharmaceutical industry organisational structure & strategies
Indian pharmaceutical industry  organisational structure & strategiesIndian pharmaceutical industry  organisational structure & strategies
Indian pharmaceutical industry organisational structure & strategiesPankaj Gaurav
 
Sun Pharma Advance Research Company Limited Presentation
Sun Pharma Advance Research Company Limited PresentationSun Pharma Advance Research Company Limited Presentation
Sun Pharma Advance Research Company Limited PresentationSubhashish Mondal
 
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...Aiswariya Chidambaram
 
Supply Chain Management Glenmark Pharma
Supply Chain Management Glenmark PharmaSupply Chain Management Glenmark Pharma
Supply Chain Management Glenmark PharmaAbhishek Dhamankar
 
Pharmaceutical Supply Chain Management
Pharmaceutical Supply Chain ManagementPharmaceutical Supply Chain Management
Pharmaceutical Supply Chain ManagementDipesh Pabrekar
 
Pharma Edetailing: the core to a new commercial approach
 Pharma Edetailing: the core to a new commercial approach Pharma Edetailing: the core to a new commercial approach
Pharma Edetailing: the core to a new commercial approachA.R.J. (Rob) Halkes
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing courseMadhukar Tanna
 
Case Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithklineCase Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithklineAanchal Saxena
 
Colgate-Palmolive Case Study
Colgate-Palmolive Case StudyColgate-Palmolive Case Study
Colgate-Palmolive Case StudySubho Mistri
 
Marketing Strategy for a medical device company
Marketing Strategy for a medical device companyMarketing Strategy for a medical device company
Marketing Strategy for a medical device companysaurabhmalani
 
Glenmark Sales & Distribution Management
Glenmark Sales & Distribution ManagementGlenmark Sales & Distribution Management
Glenmark Sales & Distribution ManagementNigam Prasad Panda
 
Digital Pharma: Evolution and Revolution in Marketing & Sales
Digital Pharma: Evolution and Revolution in Marketing & SalesDigital Pharma: Evolution and Revolution in Marketing & Sales
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
 
Marketing Plan Final
Marketing Plan FinalMarketing Plan Final
Marketing Plan FinalTeeka
 

What's hot (20)

Lupin
LupinLupin
Lupin
 
Case study examples from industry
Case study examples from industryCase study examples from industry
Case study examples from industry
 
Pharma business models
Pharma business modelsPharma business models
Pharma business models
 
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...
 
Cola war continues: Coke and Pepsi 21st century and battle for Internationa...
Cola war  continues: Coke and Pepsi 21st century and battle for  Internationa...Cola war  continues: Coke and Pepsi 21st century and battle for  Internationa...
Cola war continues: Coke and Pepsi 21st century and battle for Internationa...
 
Indian pharmaceutical industry organisational structure & strategies
Indian pharmaceutical industry  organisational structure & strategiesIndian pharmaceutical industry  organisational structure & strategies
Indian pharmaceutical industry organisational structure & strategies
 
Sun Pharma Advance Research Company Limited Presentation
Sun Pharma Advance Research Company Limited PresentationSun Pharma Advance Research Company Limited Presentation
Sun Pharma Advance Research Company Limited Presentation
 
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...
 
Supply Chain Management Glenmark Pharma
Supply Chain Management Glenmark PharmaSupply Chain Management Glenmark Pharma
Supply Chain Management Glenmark Pharma
 
Pharmaceutical Supply Chain Management
Pharmaceutical Supply Chain ManagementPharmaceutical Supply Chain Management
Pharmaceutical Supply Chain Management
 
Pharma Edetailing: the core to a new commercial approach
 Pharma Edetailing: the core to a new commercial approach Pharma Edetailing: the core to a new commercial approach
Pharma Edetailing: the core to a new commercial approach
 
Pharmaceutical Industry: The Challenges and the Opportunities
Pharmaceutical Industry: The Challenges and the OpportunitiesPharmaceutical Industry: The Challenges and the Opportunities
Pharmaceutical Industry: The Challenges and the Opportunities
 
Pfizer Inc
Pfizer IncPfizer Inc
Pfizer Inc
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing course
 
Case Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithklineCase Study Analysis on GlaxoSmithkline
Case Study Analysis on GlaxoSmithkline
 
Colgate-Palmolive Case Study
Colgate-Palmolive Case StudyColgate-Palmolive Case Study
Colgate-Palmolive Case Study
 
Marketing Strategy for a medical device company
Marketing Strategy for a medical device companyMarketing Strategy for a medical device company
Marketing Strategy for a medical device company
 
Glenmark Sales & Distribution Management
Glenmark Sales & Distribution ManagementGlenmark Sales & Distribution Management
Glenmark Sales & Distribution Management
 
Digital Pharma: Evolution and Revolution in Marketing & Sales
Digital Pharma: Evolution and Revolution in Marketing & SalesDigital Pharma: Evolution and Revolution in Marketing & Sales
Digital Pharma: Evolution and Revolution in Marketing & Sales
 
Marketing Plan Final
Marketing Plan FinalMarketing Plan Final
Marketing Plan Final
 

Viewers also liked

USCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: ChannelUSCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: ChannelStanford University
 
UCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:ChannelUCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:ChannelStanford University
 
UCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: ChannelsUCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: ChannelsStanford University
 
UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsStanford University
 
UCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsUCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsStanford University
 
UCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streamsUCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streamsStanford University
 
UCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue StreamsUCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue StreamsStanford University
 
UCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesUCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesStanford University
 
UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsStanford University
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsStanford University
 
UCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue modelsUCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue modelsStanford University
 
UCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value PropositionUCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value PropositionStanford University
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsStanford University
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Stanford University
 
BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 Stanford University
 
Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Stanford University
 
Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014Stanford University
 

Viewers also liked (20)

USCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: ChannelUSCSF Life Sciences Week 3 Diagnostics: Channel
USCSF Life Sciences Week 3 Diagnostics: Channel
 
UCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:ChannelUCSF LIfe Science Week 3 Therapeutics:Channel
UCSF LIfe Science Week 3 Therapeutics:Channel
 
UCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: ChannelsUCSF Life Science Week 3 Digital Health: Channels
UCSF Life Science Week 3 Digital Health: Channels
 
UCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 DiagnosticsUCSF Life Sciences Week 2 Diagnostics
UCSF Life Sciences Week 2 Diagnostics
 
UCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnosticsUCSF Life Sciences Week 1 diagnostics
UCSF Life Sciences Week 1 diagnostics
 
UCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streamsUCSF Life Sciences Week 5 digital health: Revenue streams
UCSF Life Sciences Week 5 digital health: Revenue streams
 
UCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue StreamsUCSF Life Sciences Week 5 Therapeutics: Revenue Streams
UCSF Life Sciences Week 5 Therapeutics: Revenue Streams
 
UCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 DevicesUCSF Life Sciences Week 1 Devices
UCSF Life Sciences Week 1 Devices
 
UCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 TherapeuticsUCSF Life Sciences Week 1 Therapeutics
UCSF Life Sciences Week 1 Therapeutics
 
UCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer SementsUCSF Life Sciences Week 2 digital health - Customer Sements
UCSF Life Sciences Week 2 digital health - Customer Sements
 
UCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue modelsUCSF Life Sciences Week 5 Diagnostics: Revenue models
UCSF Life Sciences Week 5 Diagnostics: Revenue models
 
UCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value PropositionUCSF Life Sciences Week 1 digital health - Value Proposition
UCSF Life Sciences Week 1 digital health - Value Proposition
 
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer SegmentsUCSF Life Sciences Week 2 Therapeutics: Customer Segments
UCSF Life Sciences Week 2 Therapeutics: Customer Segments
 
Knox final presentation
Knox final presentationKnox final presentation
Knox final presentation
 
Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10Magnamosis inc final presentation 12 10
Magnamosis inc final presentation 12 10
 
BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014 BCN Biosciences I-corps@nih 121014
BCN Biosciences I-corps@nih 121014
 
Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014
 
Clinacuity I-Corps@NIH 121014
Clinacuity I-Corps@NIH 121014Clinacuity I-Corps@NIH 121014
Clinacuity I-Corps@NIH 121014
 
Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014Haro Pharmaceutical I-Corps@NIH 121014
Haro Pharmaceutical I-Corps@NIH 121014
 
Affinity I-Corps@NIH 121014
Affinity I-Corps@NIH 121014Affinity I-Corps@NIH 121014
Affinity I-Corps@NIH 121014
 

Similar to UCSF Lean Launchpad Medical Device Channels

UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsUCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsStanford University
 
UCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices PartnershipsUCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices PartnershipsStanford University
 
2016 analyst and investor day presentation
2016 analyst and investor day presentation2016 analyst and investor day presentation
2016 analyst and investor day presentationir_stjude
 
Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2ir_stjude
 
2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentationir_stjude
 
Vertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignVertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignGary Leikin
 
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...LeeSam111
 
Medical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinMedical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinGaurav Mishra
 
Market access medical devices-white paper
Market access medical devices-white paperMarket access medical devices-white paper
Market access medical devices-white paperDr. Kavita Lamror
 
Market access medical devices white paper
Market access medical devices white paperMarket access medical devices white paper
Market access medical devices white paperDr. Kavita Lamror
 
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...Hexa Reports
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HISThe Gemini
 
IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014Stanford University
 
VentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. PresentationVentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. PresentationChadLevesque1
 
What is Medical Technology? : 3 Best Ways | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways  | The Lifesciences MagazineWhat is Medical Technology? : 3 Best Ways  | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways | The Lifesciences MagazineThe Lifesciences Magazine
 

Similar to UCSF Lean Launchpad Medical Device Channels (20)

UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsUCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
 
Low fidelitydeck-Team Emergent
Low fidelitydeck-Team EmergentLow fidelitydeck-Team Emergent
Low fidelitydeck-Team Emergent
 
UCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices PartnershipsUCSF Life Sciences: Week 6 Devices Partnerships
UCSF Life Sciences: Week 6 Devices Partnerships
 
Savita NYU 2015
Savita NYU 2015Savita NYU 2015
Savita NYU 2015
 
HSC_Presentation
HSC_PresentationHSC_Presentation
HSC_Presentation
 
2016 analyst and investor day presentation
2016 analyst and investor day presentation2016 analyst and investor day presentation
2016 analyst and investor day presentation
 
Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2Stj 2016 analyst and investor day presentation v2
Stj 2016 analyst and investor day presentation v2
 
2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation
 
Vertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaignVertical market expansion hc gleikin2013q4campaign
Vertical market expansion hc gleikin2013q4campaign
 
1660 - Scope Article
1660 - Scope Article1660 - Scope Article
1660 - Scope Article
 
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
Patient Monitoring Equipment Market shares anticipated to reach $26.2 billion...
 
Medical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 BerlinMedical Device Forum Speaker 2015 Berlin
Medical Device Forum Speaker 2015 Berlin
 
MedAid 2017
MedAid 2017MedAid 2017
MedAid 2017
 
Market access medical devices-white paper
Market access medical devices-white paperMarket access medical devices-white paper
Market access medical devices-white paper
 
Market access medical devices white paper
Market access medical devices white paperMarket access medical devices white paper
Market access medical devices white paper
 
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
Global Patient Monitoring Equipment Market Size, Insights and Strategies, 201...
 
The Gemini Generic HIS
The Gemini Generic HISThe Gemini Generic HIS
The Gemini Generic HIS
 
IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014IGI Technologies I-Corps@NIH 121014
IGI Technologies I-Corps@NIH 121014
 
VentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. PresentationVentriPoint Diagnostic Ltd. Presentation
VentriPoint Diagnostic Ltd. Presentation
 
What is Medical Technology? : 3 Best Ways | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways  | The Lifesciences MagazineWhat is Medical Technology? : 3 Best Ways  | The Lifesciences Magazine
What is Medical Technology? : 3 Best Ways | The Lifesciences Magazine
 

More from Stanford University

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power CompetitionStanford University
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Stanford University
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedStanford University
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedStanford University
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons LearnedStanford University
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Stanford University
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionStanford University
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Stanford University
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberStanford University
 

More from Stanford University (20)

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power Competition
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power Competition
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power Competition
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons Learned
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons Learned
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learned
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power Competition
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power Competition
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power Competition
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power Competition
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
 

Recently uploaded

USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...JojoEDelaCruz
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationRosabel UA
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsManeerUddin
 

Recently uploaded (20)

Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translation
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture hons
 

UCSF Lean Launchpad Medical Device Channels

  • 1. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 3 Channels October 15, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchpad - Allan May ©
  • 2. MEDICAL DEVICE MARKETS ARE PHYSICAL MARKETS  Medical devices encompass a large range of tangible and intangible items with a wide variety of business models and issues          Imaging equipment, such as MRI, CT and ultrasound Therapeutic capital equipment, such as Stereotactic radiosurgery, lasers, and surgical robots Implants, such as total joints, pacemakers, stents, and artificial corneas Instruments and tools, such as scalpels, syringes, and electrocautery Devices, such as catheters, introducers, and sheaths Monitoring equipment, such as glucometers, pulse oximetry, and vital signs monitors Durable medical equipment, such as crutches, wheelchairs, and home oxygen Disposables, such as syringes, wound dressings, and casts Medical devices generally require physical delivery  Exceptions:  Software based products  Morpheus: Enhanced imaging data via post processing  Physician office management software  Big Data based products UCSF Lean Launchpad - Allan May ©
  • 3. MEDICAL DEVICE CHANNELS TEND TO BE DIRECT   Most devices are sold to hospitals, physicians or patients directly Most medical devices require direct sales    There is often an educational/training component to the sales known as the “learning curve” Sales and clinical applications personnel often guide physicians through the learning curve In some products, sales and clinical applications specialists attend each procedure at which the device is used   Commonly a sales rep and tech rep send an entire day to assist a single product usage Some Medical device products/sectors use distributors    Distribution channels vary by clinical area: Eg, spine devices and surgical instruments tend to use distributors Commodity type items, such as hospital supplies, tend to use distributors Distribution channels also vary by geography  OUS markets tend to be much more distributor dominated UCSF Lean Launchpad - Allan May ©
  • 4. MEDICAL DEVICE CHANNELS TEND TO BE DIRECT (2)  OEMing components to larger manufactures is generally low margin, hard to exit businesses  The negotiating power lies mainly with the manufacturer  VARs are virtually non-existent since any alterations of approved devices require separate clinical trials and regulatory approvals  EG, adding a steroid to the tip of a pacemaker to prevent fibrosis  Retail channels exist but solely in consumer products  Hearing aids, eye glasses, wound dressings UCSF Lean Launchpad - Allan May ©
  • 5. MARKETING AND SELLING MEDICAL DEVICES CAN BE A RISKY STRATEGY   Getting and keeping medical device customers often results in wasteful duplication of resources GMP manufacturing, quality systems, QA/QC, and sales and marketing infrastructure are required in order to Market and Sell  These systems and processes are very expensive to finance   Sales people tend to cost >$350-400k/year fully loaded   It normally takes one or more dilutive equity rounds Clinical applications or technical support specialists are required to assist sales and marketing Most acquirers have extensive manufacturing infrastructure and dedicated sales and marketing forces   So they don’t pay extra value in exits for duplicative resources They DO pay for proof of penetration and uptake, but that tends to take >1-2 years and be very expensive in terms of cash burn  Requires substantial funding capital usually from venture capitalists or corporate venture capital groups UCSF Lean Launchpad - Allan May ©
  • 6. ALTERNATIVE STRATEGIES FOR SELLING MEDICAL DEVICES  What is it you are trying to prove?    Revenue, or revenue ramp to get a multiple of sales on exit? KOL uptake? Clinical viability?  Building a sales and marketing force and ramping sales is expensive, risky and time consuming  A targeted, focused rollout can be equally effective  Converting key customers of strategics is a very effective way to get the attention of acquirers     Target hospitals where their KOLs practice Target major hospitals/customers in their sales channel Demonstrate physician/patient satisfaction and build clinical experience Price/Dreams beats Price/Earnings in most cases! UCSF Lean Launchpad - Allan May ©
  • 7. CHANNEL PROFIT FIT IN MEDICAL DEVICES  Gross margin impacts distribution method and exit  First Gen medical devices often have 40-50% margins  Medical device distributors tend to require >25% margins, which is a major reason distribution is often not a viable channel  Normally, all available cash in medical device startups is spent proving safety and efficacy  Cost engineering or cost reduction usually comes in the Series C round or later  It commonly takes 6-12 months (or longer) to reduce costs and maintain safety and efficacy  Medical device acquirers will require products with >65% margins   Sometimes a clear engineering pathway to COGs reductions is sufficient without actually spending the cash to prove it Sometimes larger volumes driven by the large sales and marketing forces of major device companies can achieve COGS and economies of scale unobtainable by startups UCSF Lean Launchpad - Allan May ©
  • 8. UCSF Lean Launchpad For Life Science and Healthcare Startups Medical Device Track Class 3 Channels October 15, 2013 Allan May Chairman, Life Science Angels amay@lifescienceangels.com UCSF Lean Launchpad - Allan May ©